Boc-L-beta-HIle-OH

Boc-L-beta-HIle-OH is a Boc-protected amino acid derivative built on the L-configuration beta-hydroxyisoleucine scaffold, providing a protected alpha-amino group for controlled peptide coupling and a side-chain hydroxyl functionality that can be leveraged for downstream derivatization or for tuning polarity and hydrogen-bonding in peptide sequences. As a Boc amino acid, it is commonly used in protected-amino-acid workflows where acid-labile deprotection and subsequent condensation steps are required to assemble defined peptide structures. The presence of the side-chain alcohol makes it particularly relevant for constructing peptides that require hydroxyl-bearing residues or for preparing intermediates that later undergo selective functional group transformation.

1. Boc-Based Peptide Building Block

Boc-L-beta-HIle-OH is used as a protected amino acid building block for custom peptide synthesis where a beta-hydroxyisoleucine residue is required at a defined position. Researchers in peptide chemistry and peptide drug discovery employ this reagent to incorporate a hydroxyl-bearing side chain into short peptides, peptide fragments, and larger sequence constructs, supporting structure-property studies that depend on side-chain hydrogen bonding and increased hydrophilicity. The Boc protection pattern supports standard Boc-compatible coupling workflows, making it a practical choice for laboratories assembling peptides via stepwise protected-amino-acid chemistry and for teams producing sequence-specific intermediates for further functionalization.

2. Hydroxyl-Functionalized Peptide Intermediate

Boc-L-beta-HIle-OH is frequently selected when the downstream peptide or peptide intermediate needs a side-chain alcohol handle for later derivatization. In chemical biology and medicinal chemistry programs, hydroxyl-functional residues are used to enable selective conjugation strategies, to introduce polarity for solubility tuning in peptide libraries, or to prepare protected peptide intermediates that can be transformed into esters, ethers, or other oxygen-linked derivatives. The beta-hydroxy side chain provides a chemically meaningful functional motif while the Boc-protected amino group keeps the amino functionality controlled during sequence assembly, supporting reproducible incorporation into peptide segments prior to orthogonal downstream modifications.

3. Peptide Library SAR Development

Boc-L-beta-HIle-OH supports structure-activity relationship (SAR) and sequence optimization efforts in peptide research by enabling systematic variation of hydroxyl-containing residues within peptide scaffolds. Medicinal chemistry groups use this building block to generate defined analog series where the presence and position of a beta-hydroxy side chain are treated as variables affecting conformational preferences, intermolecular interactions, and overall physicochemical character. Because the reagent is already protected for amino-group participation, it streamlines the synthesis of analogs that differ specifically at the beta-hydroxyisoleucine position, supporting efficient generation of peptide panels for downstream characterization and comparative studies.

4. Pharmaceutical Intermediate Synthesis

Boc-L-beta-HIle-OH is also applied as a protected amino acid intermediate in the development of peptide-based pharmaceutical candidates and related chemistry programs that require hydroxyl-bearing amino acid units as precursors. Process and synthetic development teams use such Boc-protected intermediates to build well-defined peptide fragments that can serve as key intermediates for larger assembly steps, including the preparation of advanced coupling-ready segments. The combination of Boc protection and the beta-hydroxy side chain makes the reagent a practical starting point for generating oxygen-functionalized peptide intermediates used in medicinal chemistry synthesis campaigns and in custom peptide manufacturing workflows.

1. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists